September 30, 2016/NSE

Today, we announce the completion of the divestment of the GlaxoSmithKline Consumer Nigeria plc Drinks bottling and distribution business to Suntory Beverage & Food Nigeria Limited (SBFN). This follows the recent approvals obtained from the shareholders and the Nigeria Securities & Exchange Commission ( ›EC).

Following this approval, GSK has transferred ownership of the Drinks business in Nigeria to Suntory Beverage & Food Nigeria Ltd effective 1″ October 2016.

The new GSK Consumer Healthcare Company (retained business) consists of the Consumer Healthcare Wellness, Oral Healthcare and Nutrition categories and Pharmaceutical business, with a portfolio of leading healthcare brands. The retained brands include Sensodyne, Macleans, Panadol, Horlicks, Andrews Liver Salts, Voltaren, Otrivin and CAC 1000. GSK Nigeria will continue to be listed on the Nigerian Stock Exchange (NSE).

In the light of the successful completion of the divestment, the Register of Members and Register of Transfers  of the  Company  will  be closed from  Monday 3rd  October  2016 to  Friday 71    October 2016, both days inclusive. Dividend warrants for the special dividend declared by the Company at its Extraordinary General Meeting of 4t/ July, 2016, subject to appropriate withholding tax deductions, will  be  posted  on  htm  October  2016  to  holders  of  shares  whose  name  appear  in  the  Register of Members at close of business on 30″  September 2016.